|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.46/-0.12
|
Enterprise Value
2.08B
|
Balance Sheet |
Book Value Per Share
0.51
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
251.46M
|
Operating Revenue Per Share
0.15
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/02 08:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services. |